JUSTIN MASUD: Open Payments
NPI 1134885163 · FLEMING ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 40 payments from 14 companies in 2025. Trend: 2023 $77 · 2024 $5,283 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $147 |
| Merck Sharp & Dohme LLC | 7 | $135 |
| SCPHARMACEUTICALS INC. | 1 | $125 |
| United Therapeutics Corporation | 2 | $123 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $120 |
| Abbott Laboratories | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| Actelion Pharmaceuticals US, Inc. | 3 | $82 |
| PFIZER INC. | 3 | $76 |
| Alnylam Pharmaceuticals Inc. | 4 | $72 |
Products named: FUROSCIX, LifeVest, XACT, CAMZYOS, VERQUVO, VYNDAQEL, LEQVIO, AMVUTTRA.
Industry payments across FL — which companies pay providers there.
